Trial intelligence / Profile preview

PRP versus hyaluronic acid for hip osteoarthritis

2014-004120-21Phase 3Completed

Sponsor
Andalusian Progress and Health Public Foundation
Start
Jun 2015
Modality
Recombinant Proteins and Enzymes, Adoptive Cell Transfer → Cell Therapies
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hip osteoarthritis comparing Platelet rich plasma with Hyaluronic acid control (2 arms). Primary endpoint: WOMAC score comparison between treatment groups. Started Jun 2015; status: completed.

02

Drugs

autologous platelet-rich plasmasodium hyaluronate
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on 2014-004120-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004120-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call